The aryl hydrocarbon receptor: A diagnostic and therapeutic target in glioma

Volume: 27, Issue: 2, Pages: 422 - 435
Published: Feb 1, 2022
Abstract
Glioblastoma multiforme (GBM) is a deadly disease; 5-year survival rates have shown little improvement over the past 30 years. In vivo positron emission tomography (PET) imaging is an important method of identifying potential diagnostic and therapeutic molecular targets non-invasively. The aryl hydrocarbon receptor (AhR) is a transcription factor that regulates multiple genes involved in immune response modulation and tumorigenesis. The AhR is...
Paper Details
Title
The aryl hydrocarbon receptor: A diagnostic and therapeutic target in glioma
Published Date
Feb 1, 2022
Volume
27
Issue
2
Pages
422 - 435
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.